Hims & Hers struck a GLP-1 deal with Lilly. Its stock is rallying.

As part of the agreement, Hims said it won’t compound GLP-1 medications like Zepbound in the future

1 sources · 2 articles · updated 2026-11-06 16:29 UTC · business

Coverage

1. Hims & Hers struck a GLP-1 deal with Lilly. Its stock is rallying.

   MarketWatch · 2026-11-06 16:29 UTC

   As part of the agreement, Hims said it won’t compound GLP-1 medications like Zepbound in the future

   Summary on nerom.app

2. Hims & Hers struck a GLP-1 deal with Lilly. Its stock is rallying.

   MarketWatch · 2026-11-06 16:29 UTC

   As part of the agreement, Hims said it won’t compound GLP-1 medications like Zepbound in the future

   Summary on nerom.app